Managing the Burden of Prurigo Nodularis: The Role of Emerging Therapies

Join Dr. Gil Yosipovitch for a Virtual CME Lecture on Prurigo Nodularis!

Date: Monday, February 13, 2023

Presentation: 6:00 PM – 7:00 PM MST, 8:00 PM – 9:00 PM EST

Registration is required to receive the meeting link.

PROVIDER STATEMENT

Provided by Integrity Continuing Education, Inc.

In partnership with Colorado Dermatologic Society, Florida Society of Dermatology and Dermatologic Surgery, and Phoenix Dermatologic Society.

DISCLOSURE OF COMMERCIAL SUPPORT

This activity is supported by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals.

PROGRAM OVERVIEW

Prurigo nodularis (PN) is a chronic, debilitating cutaneous disease with limited treatment options that exerts significant disease burden on patients. More than half of patients (61%) report that itch exerts a great impact on sleep.  For many patients with PN, there is also a high prevalence of psychiatric comorbidities such as depression and anxiety.

This activity is designed to improve knowledge of disease pathogenesis, increase diagnostic awareness, and examine emerging therapies and their potential role in treatment. Engage with expert faculty, Dr. Yosipovitch, as he dialogues and explores theoretical patient cases.

FACULTY

Gil Yosipovitch, MD 
Professor of Dermatology
Stiefel Chair of Medical Dermatology
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery
Miller School of Medicine at University of Miami
Director, Miami Itch Center
Miami, Florida

TARGET AUDIENCE

This educational program is designed for dermatology MDs, NPs, and PAs involved in the management of patients with PN.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Apply available evidence and criteria to identify common symptoms and associated cycles of quality-of-life impact to support earlier diagnosis of PN
  • Identify known factors involved in the pathogenesis of PN
  • Utilize available guidance for the treatment of patients with PN
  • Evaluate clinical evidence supporting use of current and investigational agents for the management of PN

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. To receive credit, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • View the live broadcast
  • Complete the posttest evaluation form at the end of the program

Your certificate will be sent to you within four weeks of receipt of the completed evaluation.

MEDIA

Internet

ACCREDITATION STATEMENT

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

Gil Yosipovitch, MD 
Consultant: Abbvie, Arcutis, Bellus, Celldex, Eli Lilly, Escient, Galderma, LEO, Novartis, Pfizer, Pierre Fabre, Regeneron, Sanofi, Trevi Therapeutics
Research: Celldex, Eli Lilly, Escient, Galderma, LEO, Novartis, Pfizer, Regeneron, Sanofi, Trevi Therapeutics

The Integrity Continuing Education, Inc. planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Global Education Group do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10
• Adobe® Flash® Player 10 plug-in should be downloaded
• Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus
For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Agenda

On the day of the program, you may access the event by going to the following link: https://www.integrityce.com/PN-Live. Once you submit your answers to the pretest, you will be redirected to the zoom meeting.

There are no fees for participating and receiving CME credit for this activity. For your participation you will be able to receive a maximum of 1.0 AMA PRA Category 1 CME creditTM. To do so, you must participate in the virtual livestream activity and complete the posttest and evaluation following the event. A statement of credit will be issued within 4 weeks of submission of a completed activity evaluation form.